BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 17501969)

  • 1. A cerebellar demyelinating lesion following treatment of acne with isotretinoin.
    Yaman M; Albayram S; Altintas A; Yeni SN; Karaagac N; Islak C
    Clin Exp Dermatol; 2008 Mar; 33(2):118-21. PubMed ID: 17501969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sacroiliitis and polyneuropathy during isotretinoin treatment.
    Eksioglu E; Oztekin F; Unlu E; Cakci A; Keyik B; Karadavut IK
    Clin Exp Dermatol; 2008 Mar; 33(2):122-4. PubMed ID: 17725657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of clinical efficacy, side effects, and laboratory changes among patients with acne vulgaris receiving single versus twice daily dose of oral isotretinoin.
    Ahmad HM
    Dermatol Ther; 2015; 28(3):151-7. PubMed ID: 25754162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral isotretinoin for acne, adjusting treatment according to patient's response.
    Ghaffarpour G; Mazloomi S; Soltani-Arabshahi R; Seyed KS
    J Drugs Dermatol; 2006 Oct; 5(9):878-82. PubMed ID: 17039654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute acne flare following isotretinoin administration: potential protective role of low starting dose.
    Borghi A; Mantovani L; Minghetti S; Virgili A; Bettoli V
    Dermatology; 2009; 218(2):178-80. PubMed ID: 19060474
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of acne with intermittent and conventional isotretinoin: a randomized, controlled multicenter study.
    Akman A; Durusoy C; Senturk M; Koc CK; Soyturk D; Alpsoy E
    Arch Dermatol Res; 2007 Dec; 299(10):467-73. PubMed ID: 17710426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence of sacroiliitis in patients with acne vulgaris using isotretinoin.
    Baykal Selçuk L; Aksu Arıca D; Baykal Şahin H; Yaylı S; Bahadır S
    Cutan Ocul Toxicol; 2017 Jun; 36(2):176-179. PubMed ID: 27764978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of acne with oral isotretinoin in patients with cystic fibrosis.
    Perera E; Massie J; Phillips RJ
    Arch Dis Child; 2009 Aug; 94(8):583-6. PubMed ID: 19465582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isotretinoin therapy and the incidence of acne relapse: a nested case-control study.
    Layton AM; Dréno B; Gollnick H; Mobaken H; Shear N
    Br J Dermatol; 2009 Jan; 160(1):217-8; author reply 218-9. PubMed ID: 19067687
    [No Abstract]   [Full Text] [Related]  

  • 10. New onset of axial spondyloarthropathy in patients treated with isotretinoin for acne vulgaris: incidence, follow-up, and MRI findings.
    Elnady B; Elkhouly T; Dawoud NM; Desouky DE; Kewan HH; Dawoud DM; Ritchlin C
    Clin Rheumatol; 2020 Jun; 39(6):1829-1838. PubMed ID: 32034553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective case series of isotretinoin outcomes for acne in 393 female patients at Baylor College of Medicine during 2012-2016.
    Fernandez J; Lee B; Patel JM; Weiss E; Jiang J; Dao H; Kim SJ
    J Am Acad Dermatol; 2020 May; 82(5):1218-1219. PubMed ID: 31443910
    [No Abstract]   [Full Text] [Related]  

  • 12. A dietary supplement to reduce side effects of oral isotretinoin therapy in acne patients.
    Fabbrocini G; Cameli N; Lorenzi S; De Padova MP; Marasca C; Izzo R; Monfrecola G
    G Ital Dermatol Venereol; 2014 Aug; 149(4):441-5. PubMed ID: 25068233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is oral isotretinoin the treatment of choice in moderate and severe inflammatory acne vulgaris?
    Verros CD; Rallis E
    J Eur Acad Dermatol Venereol; 2007 Oct; 21(9):1270-1. PubMed ID: 17894728
    [No Abstract]   [Full Text] [Related]  

  • 14. Giant cobblestone-like papillae during isotretinoin therapy.
    Rosen E; Raz J; Segev F
    Ocul Immunol Inflamm; 2009; 17(5):312-3. PubMed ID: 19831559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose isotretinoin treatment and the rate of retrial, relapse, and adverse effects in patients with acne vulgaris.
    Blasiak RC; Stamey CR; Burkhart CN; Lugo-Somolinos A; Morrell DS
    JAMA Dermatol; 2013 Dec; 149(12):1392-8. PubMed ID: 24173086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient Perspectives: Treating acne with isotretinoin.
    Pediatr Dermatol; 2015; 32(6):e324-5. PubMed ID: 26584707
    [No Abstract]   [Full Text] [Related]  

  • 17. Isotretinoin treatment in patients with acne vulgaris: does it impact muscle strength, fatigue, and endurance?
    Yıldızgören MT; Rifaioğlu EN; Demirkapı M; Ekiz T; Micooğulları A; Şen T; Turhanoğlu AD
    Cutis; 2015 Jul; 96(1):33-6. PubMed ID: 26244352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On isotretinoin dosing, adverse effects, and efficacy.
    Berk DR
    Australas J Dermatol; 2011 May; 52(2):147-8; author reply 148. PubMed ID: 21605103
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of the efficacies of intermittent and continuous low-dose isotretinoin regimens in the treatment of moderate acne vulgaris.
    Boyraz N; Mustak PK
    Int J Dermatol; 2013 Oct; 52(10):1265-7. PubMed ID: 23675954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Terminal hematuria associated with oral isotretinoin treatment in a patient with acne vulgaris.
    Sarifakioglu E; Yilmaz AE; Erpolat S
    Pediatr Dermatol; 2012; 29(5):668-9. PubMed ID: 22067016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.